¼¼°èÀÇ Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ Ä¡·á ½ÃÀå(2025-2029³â)
Global Treatment Resistant Depression Therapeutics Market 2025-2029
»óǰÄÚµå : 1626161
¸®¼­Ä¡»ç : TechNavio
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 201 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,500 £Ü 3,617,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,000 £Ü 5,787,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ Ä¡·á ½ÃÀå, 2025-2029³â

Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ Ä¡·á ½ÃÀåÀº 2024-2029³â¿¡ 20¾ï 6,100¸¸ ´Þ·¯, ¿¹Ãø ±â°£ Áß CAGRÀº 6.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ Ä¡·á ½ÃÀåÀÇ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¡¤¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ÀÇ º¥´õ¸¦ ´Ù·é º¥´õ ºÐ¼® µîÀ» °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¿ì¿ïÁõÀÇ ³ôÀº À¯º´·ü, ÁïÈ¿¼º Ç׿ì¿ïÁ¦¿¡ ´ëÇÑ ÁÖ·Â, Á¤½Å°Ç°­¿¡ ´ëÇÑ ÅõÀÚ µîÀÌ ½ÃÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁسâ 2025³â
Á¾·á³â 2029³â
¿¹Ãø ±â°£ 2025-2029³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³â´ëºñ[2025³â 5.8%
CAGR 6.1%
ÁõºÐ¾× 20¾ï 6,100¸¸ ´Þ·¯

º» Á¶»ç¿¡¼­´Â ÇâÈÄ ¼ö³â°£ Ä¡·á ÀúÇ×¼º ¿ì¿ïÁõ Ä¡·á ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ Çϳª·Î ÀǾàǰ °³¹ß¿¡¼­ aiÀÇ ºÎ»óÀ» µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±ÔÁ¦±â°üÀÇ ½ÂÀÎ Áõ°¡ ¹× ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ÁÖ¸ñµµ ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Technavio ºÐ¼®

Á¦3Àå ½ÃÀå ±¸µµ

Á¦4Àå ½ÃÀå ±Ô¸ð

Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû

Á¦6Àå Á¤¼º ºÐ¼®

Á¦7Àå Five Forces ºÐ¼®

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Åë ä³Îº°

Á¦9Àå ½ÃÀå ¼¼ºÐÈ­ : À¯Çüº°

Á¦10Àå °í°´ »óȲ

Á¦11Àå Áö¿ªº° »óȲ

Á¦12Àå ÃËÁø¿äÀΡ¤°úÁ¦¡¤±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå °æÀï ºÐ¼®

Á¦15Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Treatment Resistant Depression Therapeutics Market 2025-2029

The treatment resistant depression therapeutics market is forecasted to grow by USD 2061 mn during 2024-2029, accelerating at a CAGR of 6.1% during the forecast period. The report on the treatment resistant depression therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high prevalence of depression, focus on rapid-acting antidepressants, and investments in mental health.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20255.8%
CAGR6.1%
Incremental Value$2061 mn

Technavio's treatment resistant depression therapeutics market is segmented as below:

By Distribution Channel

By Type

By Geographical Landscape

This study identifies the emergence of ai in drug development as one of the prime reasons driving the treatment resistant depression therapeutics market growth during the next few years. Also, increase in regulatory approvals and focus on personalized medicine will lead to sizable demand in the market.

The report on the treatment resistant depression therapeutics market covers the following areas:

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading treatment resistant depression therapeutics market vendors that include AbbVie Inc., Acadia Pharmaceuticals Inc., Alkermes Public Ltd. Co., AstraZeneca Plc, Axsome Therapeutics Inc., Eli Lilly and Co., Evotec SE, H Lundbeck AS, Intra-Cellular Therapies Inc, Johnson and Johnson Inc., Numinus Wellness Inc, Otsuka Pharmaceutical Co. Ltd., Pfizer Inc., Sage Therapeutics Inc, Stella MSO LLC dba Field Trip Health, Sumitomo Pharma Co. Ltd., Teva Pharmaceutical Industries Ltd., and Vistagen Therapeutics Inc. Also, the treatment resistant depression therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Distribution Channel

9 Market Segmentation by Type

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â